Ricardo Santos, Secretary-General of the Portuguese Pharmaceutical Society, visited Mozambique in early June as part of an institutional visit that coincided with the event of the African Vaccine Regulatory Forum (AVAREF), an initiative of WHO Africa that supports African countries in the assessment of clinical trials and the regulation of vaccines and medicines, promoting technical training and international cooperation.
It was in this context that he had the opportunity to exchange views on the CT-Luso Project with several international partners attending the event, further strengthening the shared interest in promoting capacity building and international cooperation in clinical research.
AVAREF provides technical advice and support on clinical trials and emergency use authorisations. Support to regulatory authorities includes facilitating pre-submission meetings and joint assessments by several countries as part of the authorisation of clinical trials, with the aim of supporting the timely registration of new vaccines and medicines.
